[Treatment of bronchial inflammatory disorders with guacetisal].
A comparative trial conducted on 48 male and 9 female patients suitably selected in terms of indication consisted of a first stage in which a completely random, doubleblind comparison was made between acetylsalicylic acid, guacetisal and guaiacol carbonate (preparations A, B, and C) while in the second stage an association of bromexine, acetylsalicylic acid and codeine phosphate (preparation D) was examined in terms of activity and tolerance in an open trial. Statistical analysis showed the superiority of preparation B with respect to most of the parameters taken into consideration.
D000208:Acute Disease; D001241:Aspirin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D001964:Bromhexine / Q000627:therapeutic use; D001991:Bronchitis / Q000188:drug therapy*; D002254:Carbonates / Q000627:therapeutic use; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D003061:Codeine / Q000627:therapeutic use; D003371:Cough / Q000188:drug therapy; D005260:Female; D006139:Guaiacol / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged
D002254:Carbonates; D006139:Guaiacol; D001964:Bromhexine; D001241:Aspirin; C023557:guacetisal; D003061:Codeine
Trattamento delle forme infiammatorie bronchiali con guacetisal.